Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023

SELL
$0.64 - $1.99 $9,200 - $28,606
-14,375 Reduced 57.24%
10,740 $11,000
Q3 2022

Nov 14, 2022

SELL
$2.73 - $4.92 $1,638 - $2,952
-600 Reduced 2.33%
25,115 $59,000
Q2 2022

Aug 12, 2022

SELL
$2.8 - $7.67 $39,191 - $107,356
-13,997 Reduced 35.25%
25,715 $78,000
Q1 2022

May 16, 2022

BUY
$6.01 - $8.54 $13,684 - $19,445
2,277 Added 6.08%
39,712 $270,000
Q4 2021

Feb 14, 2022

SELL
$7.11 - $9.64 $1,777 - $2,410
-250 Reduced 0.66%
37,435 $313,000
Q3 2021

Nov 15, 2021

BUY
$5.04 - $8.73 $1,260 - $2,182
250 Added 0.67%
37,685 $280,000
Q2 2021

Aug 13, 2021

SELL
$6.58 - $10.66 $13,489 - $21,853
-2,050 Reduced 5.19%
37,435 $255,000
Q1 2021

May 14, 2021

SELL
$6.73 - $13.87 $11,945 - $24,619
-1,775 Reduced 4.3%
39,485 $406,000
Q4 2020

Feb 12, 2021

SELL
$6.37 - $10.33 $8,121 - $13,170
-1,275 Reduced 3.0%
41,260 $289,000
Q3 2020

Nov 09, 2020

SELL
$4.58 - $10.95 $3,022 - $7,226
-660 Reduced 1.53%
42,535 $347,000
Q2 2020

Aug 13, 2020

BUY
$4.17 - $7.58 $1,939 - $3,524
465 Added 1.09%
43,195 $298,000
Q1 2020

May 14, 2020

BUY
$2.91 - $8.7 $46,239 - $138,243
15,890 Added 59.2%
42,730 $203,000
Q4 2019

Feb 14, 2020

BUY
$2.81 - $9.21 $11,366 - $37,254
4,045 Added 17.75%
26,840 $234,000
Q3 2019

Nov 13, 2019

BUY
$3.33 - $4.93 $75,907 - $112,379
22,795 New
22,795 $76,000

Others Institutions Holding JNCE

About Jounce Therapeutics, Inc.


  • Ticker JNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,694,200
  • Description
  • Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...
More about JNCE
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.